| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |